Ethical Issues in the Pharmaceuticals Industry
University of Phoenix
Ethics in Management
October 13, 2008
American and European drug companies argon the source of most of the modern medicines that have revolutionized wellnessc are in the last 20 years. Ethically, the development of new medications to safeguard health and mitigate human suffering should be fairly simple. In reality, however, there is much honest ambiguity in the development, examination and commercialize of these medications. The need to lessen human suffering frequently runs afoul of competing interests: research and development costs, the companies profit motive and indebtedness to shareholders, and the necessity for trials and testing prior to marketing the drugs, and then the marketing strategies themselves. The ethical standards of Goal-based, Human Nature, Rights-based, Duty-based, and Human Nature Ethics, provide a entire framework for an analysis of these ethical challenges, and also appoint to possible solutions.
It is unrealistic to expect a drug corporation, make of mevery different people, with disparate ethical bases, to have an externally-focused ethical code. A corporation is mostly concerned with self-perpetuation.
Most corporations are amoral, in the larger context. Goal-based ethics provide a good rationale for the conduct of pharmaceutical companies. These companies have been marketing drugs to doctors by means of fancy incentives, rather then promoting a strong product. The primary goal of a pharmaceutical company is to market drugs, make a profit, and reward shareholders, thus allowing the incumbent steering to keep their jobs. While, ideally, a corporation would have a incarnate soul, and its own ethical code focused on the great good, in reality, it is the profit motive that becomes more important than any desire to mitigate human suffering. For example, most prescription drugs subscribe to U.S...If you want to get a full essay, order it on our website: Orderessay
If you want to get a full essay, wisit our page: write my essay .
No comments:
Post a Comment